Cryptosporidiosis is a zoonotic intestinal parasitic disease caused by infection with protozoa of the genus Cryptosporidium in the subphylum Terminalia (protozoa). The lesions mainly injure the mucosa of the small intestine, and the clinical manifestations are mainly watery diarrhea, often with upper abdominal discomfort, nausea and vomiting. Immunocompetent adult patients are self-limiting, while immunodeficient or malnourished children require anti-Cryptosporidium treatment. The pathogenesis of Cryptosporidium is uncertain.
Transfection is a technique that introduces exogenous genes into eukaryotic cells and expresses them intracellularly. Using transfection technology to construct Cryptosporidium transfection vectors will provide an effective tool to study the function of Cryptosporidium genes and to screen drug target genes and protective antigen genes.
Ace Therapeutics specializes in parasitology and has established a parasite genetic engineering technology platform designed to provide genetic engineering services for a variety of parasitic diseases to clients worldwide. We are able to provide transfection services for Cryptosporidium to our global clients, laying the foundation for in-depth elucidation of mechanistic studies.
We have established the Cryptosporidium transfection system, mainly by electroporation transformation method. Our Cryptosporidium transfection service is still undergoing condition optimization and improvement. If you need to know more, please consult us for details.
Transfection of mouse intestinal epithelial cells (IEC) (liposome transfection method)
Application of Cryptosporidium gene transfection
Delivery content: experiment report and products of Cryptosporidium gene transfection
Test fee: please get it through online inquiry.
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.